Erdafitinib's effect on serum phosphate justifies its pharmacodynamically guided dosing in patients with cancer.
Dosne AG, Valade E, Stuyckens K, De Porre P, Avadhani A, O'Hagan A, Li LY, Ouellet D, Faelens R, Leirens Q, Poggesi I, Perez Ruixo JJ.
Dosne AG, et al. Among authors: li ly.
CPT Pharmacometrics Syst Pharmacol. 2022 May;11(5):569-580. doi: 10.1002/psp4.12727. Epub 2021 Nov 22.
CPT Pharmacometrics Syst Pharmacol. 2022.
PMID: 34755484
Free PMC article.